144 related articles for article (PubMed ID: 21629980)
1. Loss of heterozygosity analysis in malignant gliomas.
Mizoguchi M; Kuga D; Guan Y; Hata N; Nakamizo A; Yoshimoto K; Sasaki T
Brain Tumor Pathol; 2011 Jul; 28(3):191-6. PubMed ID: 21629980
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.
Joo M; Park SH; Chang SH; Kim H; Choi CY; Lee CH; Lee BH; Hwang YJ
Hum Pathol; 2013 Feb; 44(2):282-8. PubMed ID: 23058249
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.
Laxton RC; Popov S; Doey L; Jury A; Bhangoo R; Gullan R; Chandler C; Brazil L; Sadler G; Beaney R; Sibtain N; King A; Bodi I; Jones C; Ashkan K; Al-Sarraj S
Neuro Oncol; 2013 Dec; 15(12):1635-43. PubMed ID: 24158110
[TBL] [Abstract][Full Text] [Related]
6. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA
Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026
[TBL] [Abstract][Full Text] [Related]
7. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological diagnosis of gliomas by genotype analysis].
Nakamura M; Shimada K; Nakase H; Konishi N
Brain Nerve; 2009 Jul; 61(7):773-80. PubMed ID: 19618854
[TBL] [Abstract][Full Text] [Related]
9. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas.
Miwa T; Hirose Y; Sasaki H; Ezaki T; Yoshida K; Kawase T
Neurosurgery; 2011 Jan; 68(1):206-12. PubMed ID: 21099717
[TBL] [Abstract][Full Text] [Related]
10. Updates in prognostic markers for gliomas.
Aquilanti E; Miller J; Santagata S; Cahill DP; Brastianos PK
Neuro Oncol; 2018 Nov; 20(suppl_7):vii17-vii26. PubMed ID: 30412261
[TBL] [Abstract][Full Text] [Related]
11. Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
Kros JM; Huizer K; Hernández-Laín A; Marucci G; Michotte A; Pollo B; Rushing EJ; Ribalta T; French P; Jaminé D; Bekka N; Lacombe D; van den Bent MJ; Gorlia T
J Clin Oncol; 2015 Jun; 33(17):1943-50. PubMed ID: 25918297
[TBL] [Abstract][Full Text] [Related]
12. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
Smith JS; Alderete B; Minn Y; Borell TJ; Perry A; Mohapatra G; Hosek SM; Kimmel D; O'Fallon J; Yates A; Feuerstein BG; Burger PC; Scheithauer BW; Jenkins RB
Oncogene; 1999 Jul; 18(28):4144-52. PubMed ID: 10435596
[TBL] [Abstract][Full Text] [Related]
13. IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.
Jha P; Suri V; Sharma V; Singh G; Sharma MC; Pathak P; Chosdol K; Jha P; Suri A; Mahapatra AK; Kale SS; Sarkar C
Exp Mol Pathol; 2011 Aug; 91(1):385-93. PubMed ID: 21569770
[TBL] [Abstract][Full Text] [Related]
14. Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.
Zhang GB; Cui XL; Sui DL; Ren XH; Zhang Z; Wang ZC; Lin S
J Neurooncol; 2013 Jun; 113(2):251-8. PubMed ID: 23494873
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.
Kakkar A; Suri V; Jha P; Srivastava A; Sharma V; Pathak P; Sharma MC; Sharma MS; Kale SS; Chosdol K; Phalak M; Sarkar C
Neurol India; 2011; 59(2):254-61. PubMed ID: 21483128
[TBL] [Abstract][Full Text] [Related]
17. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients.
Jesionek-Kupnicka D; Szybka M; Potemski P; Kulczycka-Wojdala D; Jaskólski D; Bieńkowski M; Skowroński W; Papierz W; Kordek R; Zawlik I
Pol J Pathol; 2013 Dec; 64(4):268-75. PubMed ID: 24375041
[TBL] [Abstract][Full Text] [Related]
18. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
[TBL] [Abstract][Full Text] [Related]
19. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
20. Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma.
Kraus TF; Kolck G; Greiner A; Schierl K; Guibourt V; Kretzschmar HA
Tumour Biol; 2015 Nov; 36(11):8439-46. PubMed ID: 26022161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
